Related Experiment Video
Updated: Jul 11, 2026
Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Published on: June 25, 2015
A comparative study examining the cytotoxicity of inducible gene expression system ligands in different cell types
Jinger Xie1, Ayyappan Nair, Terry W Hermiston
1Novel Technologies Department, Bayer HealthCare Pharmaceutical, 2600 Hilltop Drive, Richmond, CA 94806, USA.
Abstract:
Inducible gene expression systems are being used in many in vitro and in vivo applications for target discovery, target validation and as components in exploratory therapeutic agents. Ideally, the ligands, which activate the systems, are benign so that the effects can be strictly attributed to the induced protein. As a first step to defining the potential effects of these inducers, we tested three of them, doxycycline, muristerone A and mifepristone (for tet-, ecdysone- and progesterone antagonist-inducible systems respectively), for toxicity across a panel of normal cells and cancer cell lines. In contrast to both muristerone A and mifepristone that showed no significant toxicity on any of the tested cells, we observed that doxycycline induced cell death in selected cancer and primary cell lines. The different susceptibility of cell lines to the ligands commonly used in these inducible systems suggests that it is important to consider the effects of the inducers prior to their use in experimental in vitro cell culture systems.
Insights
Doxycycline, a common inducer for gene expression systems, showed toxicity in certain cancer and primary cells. Researchers recommend evaluating inducer effects before experimental use to ensure accurate results.
Area of Science:
- Molecular Biology
- Cell Biology
- Pharmacology
Background:
- Inducible gene expression systems are crucial for target discovery, validation, and therapeutic development.
- Ligands activating these systems should ideally be non-toxic for accurate attribution of protein effects.
- Common inducers include doxycycline, muristerone A, and mifepristone for Tet-, ecdysone-, and progesterone antagonist-inducible systems, respectively.
Purpose of the Study:
- To assess the toxicity of three common inducible system ligands: doxycycline, muristerone A, and mifepristone.
- To evaluate the safety of these inducers across a range of normal and cancer cell lines.
Main Methods:
- Toxicity testing of doxycycline, muristerone A, and mifepristone.
- Inclusion of diverse normal cells and cancer cell lines in the experimental panel.
- Comparative analysis of cell death induction by each ligand.
Main Results:
- Muristerone A and mifepristone exhibited no significant toxicity in any tested cell lines.
- Doxycycline demonstrated notable toxicity, inducing cell death in specific cancer and primary cell lines.
- Varied susceptibility of cell lines to the tested ligands was observed.
Conclusions:
- The choice of inducer can significantly impact experimental outcomes due to differential cellular toxicity.
- Pre-experimental evaluation of inducer toxicity is essential for reliable in vitro cell culture studies.
- Careful consideration of inducer effects is necessary for accurate target discovery and validation using inducible systems.
More Related Videos
10:59Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment
Published on: November 23, 2017
10:13Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019